相关实验视频

Updated: Jun 15, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

针对GDF15的中和抗体,用于治疗与癌症相关的缓冲症

Junyi Xiong¹, Guojin Wu², Jinying Ning²

¹College of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, China.

|August 22, 2024

概括

一个新的单克隆抗体,KY-NAb-GDF15,有效中和生长分化因子15 (GDF15) 信号. 这种抗体对治疗癌症缓解症和化疗诱导的体重减轻有前途.

科学领域:

在瘤学瘤学.
内分泌学在内分泌学.
免疫学免疫学免疫学

背景情况:

增长分化因子15 (GDF15) 是一种调节能量平衡和体重的蛋白质.
升高的GDF15水平与癌症患者的缓解症和降低生存率相关.
GDF15激活GFRAL-RET通路,诱导体重减轻和向缓解症.

研究的目的:

开发和表征一种针对GDF15的新型单克隆抗体,用于癌症缓解症治疗.
评估抗体在阻断GDF15介导信号传递方面的有效性.
评估抗体在癌症缓解症的临床前模型中的治疗潜力.

主要方法:

产生一种单克隆抗体,KY-NAb-GDF15,对抗GDF15.
评估抗体阻断GDF15诱导的GFRAL-RET信号传递的能力.
评估抗体的结合特异性和中和活性.

主要成果:

单克隆抗体KY-NAb-GDF15有效地阻止了GDF15介导的下游信号传输.
该抗体表现出高结合特异性和强大的中和活性对GDF15.
临床前数据表明,抗体可以缓解癌症诱导的缓解和化疗相关的体重减轻.

结论:

KY-NAb-GDF15是一种针对GDF15.5的强效中和抗体.
这种抗体代表了一种有希望的治疗候选人,用于管理癌症缓解症.
用抗体治疗来准GDF15,为癌症缓解症治疗提供了一种新的策略.

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.